Scientific Program at a Glance

Wednesday
September 24, 2008
Thursday
September 25, 2008
Friday
September 26, 2008
Saturday
September 27, 2008

Saturday, September 27, 2008
07:30-08:30 Free Communications Sessions

Miscellaneous I

Convenor: Christopher Chen, Singapore

 
Cognition And Neurological Deficits Independently Predict For Functional Outcome After Stroke
Christopher Chen, Singapore

First Data On Stroke Incidence From Spain: Results From The Iberictus Project
Rafael Gabriel, Spain

Motor Cortical Disinhibition During Early And Late Recovery After Stroke
Michele Acler, Italy

Economic Hardship From Stroke In China
Emma Heeley, Australia

Trend of Stroke Incidence in a Japanese Population: Has the Decline Finally Stopped? - Takashima Stroke Registry, Japan: 1990-2001
Tanvir Chowdhury Turin, Japan

Risk Factors And Clinical Presentations Of Periventricular Venous Infarction Differ From Arterial Presumed Perinatal Ischemic Stroke
Adam Kirton, Canada

Outcome

Convenors: Tom Skyhoj Olsen, Denmark 
                     Guenter Seidel, Germany

 
How Does Dependency at 6 Months After Ischaemic Stroke Onset Affect Cause of Death in Long-Term Follow-Up?
Karsten Bruins Slot, Norway

Pathology Of Atherosclerotic Intracranial Stenosis
Jose Navarro, Philippines

Gender Differences In One-Week Stroke Mortality
Tom Skyhøj Olsen, Denmark

Evaluation Of Socioeconomic Factors Causing Discontinuation Of Secondary Preventive Treatment Against Stroke: An Analysis From Urban Stroke Clinic
Kamalesh Das, India

Very Long Term Risk Of Stroke Recurrence: The South London Stroke Register
Keerthi Michelle Mohan, UK

Female Gender Is A Predictor Of Worse Outcome In Patients Treated With Thrombolysis For Acute Stroke
Blanca Fuentes, Spain

Organized Stroke Care

Convenor: Mark J. Alberts, USA
                    Erich Bernd Ringelstein, Germany 


Promoting Thrombolysis For Acute Ischaemic Stroke:  Results Of A Cluster-Randomised Trial To Resolve Barriers To The Delivery Of Intravenous Thrombolysis
Maaike Dirks, The Netherlands

Societal Factors Of Primary Stroke Among Vietnamese Farmers
Man Nguyen, Vietnam

Effects Of Cadmium On The Vascular Endothelium In-Vivo And In-Vitro
Michael Knoflach, Austria

Nocturnal Blood Pressure Patterns Among Ischemic Stroke Patients In Singapore
Deidre De Silva, Singapore

Elevated Levels Of Lipoprotein-Associated Phospholipase A2 And Stroke Risk
Mark J. Alberts, USA

Metabolic syndrome(MS) as a risk factor(RF) for ischemic stroke(CI)    do  individual risk factors interact multiplicatively and/or by summation?
Daniel Bartko, Slovak Republic

Miscellaneous II

Convenor: Keith Muir, UK
                    Gudrun Boysen, Denmark 


The Incidence And Risk Factors For Venous Thromboembolism In Acute Stroke Patients
Kayoko Kawase, Japan

A Population-Based Study Of Predictors Of Recurrent Stroke Following Transient Ischaemic Attack-The North Dublin Stroke Study
Orla Sheehan, Ireland

Blood Pressure, Cholesterol And 55 000 Vascular Deaths Among One Million Adults: Prospective Studies Collaboration (PSC)
Sarah Lewington, UK

Failure to promote physical activity after ischaemic stroke. The exstroke pilot trial
Gudrun Boysen, Denmark

Evaluation Of D-Dimer As A Surrogate Marker For Stroke Etiology In Patients With Acute Ischemic Stroke
Raf Brouns, Belgium

Impaired Verbal Paired Associate Learning In Cadasil
Keith Muir, UK

Acute Management II

Convenor: Christian Stapf, France
                    Joanna Wardlaw, UK

Thrombolysis for acute ischaemic stroke. An update of the cochrane thrombolysis meta-analysis
Joanna Wardlaw, UK

Intravenous Thrombolysis During Inter-Hospital Transfer Of Acute Stroke Patients Is Safe And Efficient
Thomas Pfefferkorn, Germany

A Novel Thrombolysis Technology Employing Magnetically-Guided TPA Loaded Nanocarriers
Axel J. Rosengart, USA

Mechanical Clot Removal By The Penumbra System In Acute Stroke
Iris Quasar Grunwald, Germany

Brain Arteriovenous Malformations: Morphological Predictors Of Hemorrhage At Initial Presentation And After Endovascular Therapy
C Stapf, France

Transcranial Laser Treatment (TLT) For Ischemic Stroke: Long-Term Outcomes Following Nest-1
Julio Perez, Peru

08:30-10:00

Main Theme 21
Acute Ischemic Stroke: Critical Care of Ischemic Stroke

Convenors: Neeraj Badjatia, USA
                     Stefan Schwab, Germany

Decompressive Surgery in Ischemic Stroke: Still Crazy After all These Years?
Stefan Schwab, Germany

ICH - Blood Pressure and CBF: What is the Best Medical Therapy?
Michael N. Diringer, USA

Brain Edema and ICP: Is there Hope for New Interventions?
Daniel F. Hanley, USA

Temperature and Intervention: What is the Evidence?
Neeraj Badjatia, USA

Critical Care of Stroke in Latin America and South-East Asia: Obstacles and
Implementation
Patricio Mellado Talesnik, Chile

 

Main Theme 22                                                                    
Stroke Prevention
The Role of Stroke Support Organizations

Convenors: Brian O’Grady, New Zealand
                      Antonio Davalos, Spain

A Collaborative Approach to Stroke Service Development
Brian O’Grady, New Zealand

The SAFE Model of Stroke Prevention
Sandra Levy, Israel

The ASA (American Stroke Association) Model of Stroke Support
Wendy Segrest, USA

Stroke Support in Malaysia
Janet Yeo, Malaysia

Stroke Program & Stroke Foundation: A Joint Venture
Miquel Gallofre, Spain

 

Main Theme 23                                                                    
The Future of Neuro-Imaging

Convenors: Wolf-Dieter Heiss, Germany
                      Steven Warach, USA

Is there Still a Future for CT in Acute Stroke?
Rudiger Von Kummer, Germany

Innovative MR-Sequences
Steven Warach, USA

MR/PET Hybrid
Wolf-Dieter Heiss, Germany

Multimodality Imaging in Experimental Stroke
Eng H. Lo, USA

Imaging Cell Migration and Cell Therapy
Ronald G. Blasberg, USA

 

Main Theme 24                                                                    
Health Economics

Convenors: David B. Matchar, USA
                     Ruth Bonita, New Zealand

Understanding the Components of Cost for Stroke and its Prevention and Treatment, and
the Dynamic Relationship between These Components
David B. Matchar, USA

Estimating the Resource Implications of Stroke Prevention and Treatment Interventions in Different Countries  
Dede Zhao, China
   
Stroke Costs in The Overall Context of Chronic Disease: Where Are the Savings?
Ruth Bonita, New Zealand

 

Main Theme 25                                                                    
Basic Science
Translational Research: Present and Future

Convenors: Markus Schwaninger, Germany
                      Matthias Endres, Germany

Biomarkers: A Window to the Brain
Joan Montaner, Spain

Statins and Endothelial Function
Matthias Endres, Germany

Albumin on the Road to the Clinic
Myron D. Ginsberg, USA

Gene Regulation as a Drug Target in Stroke
Markus Schwaninger, Germany

10:00-10:30 Coffee Break
10:30-12:00

Lectures of Excellence
Convenors: Bo Norrving, Sweden
                      Wilfried Lang, Austria 

Neurovascular Unit
Gregory del Zoppo, USA

The Experience of the Canadian Stroke Network - Bringing Knowledge to Practice
Antoine Hakim, Canada

12:00-13:30

Plenary III
Late Breaking News / Closing Ceremony

Convenors: Michael Brainin, Austria
                      Werner Hacke, Germany

Late Breaking News Lectures:

Hamlet: hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial
Jeannette Hofmeijer, The Netherlands

Results Of The Asymptomatic Carotid Trial (Act 1) Lead In Phase
Seemant Chaturvedi, USA

Paracetamol (Acetaminophen) In Stroke (PAIS): A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial
Heleen Den Hertog, The Netherlands

The 10 Year Results Of The Asymptomatic Carotid Surgery Trial
Allison Halliday, UK

Double-Blind, Placebo-Controlled, Intra-Venous Microplasmin Administration In Patients With Acute Ischemic Stroke
Vincent Thijs, Belgium